Radiology reimbursement alerts

ULTRATAG RBC is an injectable technetium Tc 99m red blood cell labeling kit approved for intravenous administration, placing it squarely in the Medicare Part B billing pathway as a physician-administe

TAUKLARIFY (florquinitau F18) is an injectable radiopharmaceutical approved as a new molecular entity, supporting a Part B billing pathway consistent with physician-administered injectables. As an F18

This active final LCD from Wellpoint Federal governs coverage criteria for breast imaging modalities including ultrasound (echography/sonography), MRI, and ductography under Medicare Parts A and B, ef

This active final LCD from Wellpoint Federal establishes coverage criteria for Computed Tomography Cerebral Perfusion Analysis (CTP), effective April 1, 2026. It governs both Part A and Part B billing

This active final LCD (L33619) from Wellpoint Federal governs coverage of nonvascular extremity ultrasound under Part A and B, effective April 1, 2026. It establishes the medically necessary indicatio

This active final LCD from Wellpoint Federal governs coverage criteria for Magnetic Resonance Angiography (MRA) under Medicare Part A and Part B, effective April 1, 2026. It defines the clinical indic

This active final LCD (L33578) from Wellpoint Federal governs coverage of Transrectal Ultrasound under Medicare Part A and Part B, effective April 1, 2026. It establishes specific indications, coverag

This active final LCD from Wellpoint Federal governs coverage criteria for Stereotactic Radiosurgery (SRS) and Stereotactic Body Radiation Therapy (SBRT) under both Part A and Part B, effective April

ZYOGREEN (indocyanine green injection) was approved as a new dosage form (NDA218579) for intravenous administration, placing it squarely in the Part B billing pathway as a provider-administered inject

Ambelvist (Gadoquatrane) is approved for intravenous administration, indicating that billing will follow the Part B pathway. As it is designated as an orphan drug, it may qualify for special considera

The finalized LCD L33459 outlines billing guidelines for Computerized Axial Tomography (CT) of the thorax, effective 06/11/2026. Providers in the impacted states should review the guidelines thoroughl

The proposed LCD for Non-invasive Arterial Duplex Ultrasound may lead to an increase in imaging services for assessing vascular health, impacting reimbursement rates positively for practices that perf

The proposed LCD for non-invasive arterial duplex ultrasound of the upper and lower extremities may lead to supports compliance with updated rates for providers in the relevant specialties. This could i

The proposed LCD for automated detection and quantification of brain MRIs could streamline the billing process for radiologists and improve reimbursement rates for these services. By standardizing eva

The proposed Local Coverage Determination (LCD) for Computed Tomography Cerebral Perfusion Analysis (CTP) requires billing team review. This could increase

The introduction of the LCD for Computed Tomography Cerebral Perfusion Analysis (CTP) requires billing team review. It allows for clearer guidelines on reimbursem

The implementation of the new LCD for Computed Tomography Cerebral Perfusion Analysis (CTP) by Noridian may affect billing practices and reimbursement rates for practices conducting these tests. Provi

The incoming LCD BDX-XL2 by Noridian effective from 10/23/2025 may lead to changes in reimbursement protocols for relevant procedures. Providers should prepare for potential alterations in covered ind

The introduction of new LCD for Lumbar MRI by Noridian will require practices to review their current billing processes to ensure compliance with the updated regulations. This may impact reimbursement

With the implementation of the Noridian LCD on MRI and CT Scans of the Head and Neck effective 10/23/2025, providers must ensure that their billing practices align with the updated guidelines to avoid

The Lumbar MRI LCD by Noridian, effective from August 2022, could lead to an increase in approved claims for lumbar imaging. This requires billing team review

The LCD on MRI and CT scans of the head and neck by Noridian may impact billing practices for providers by establishing specific indications and limitations for these imaging procedures. Providers mus

The Noridian Chest X-Ray LCD effective from 11/06/2025 may result in changes to claims reimbursement. Providers should be prepared for potential updates in coverage criteria that could impact billing

The implementation of the LCD for Non-Invasive Vascular Studies will likely alter the reimbursement landscape, potentially affecting the revenue streams of providers. It is essential for billing teams

The Chest X-Ray policy from Noridian may impact billing by establishing specific criteria for coverage, potentially limiting the types of services that can be billed under Medicare. Providers should e

The new Local Coverage Determination (LCD) for Breast Imaging will significantly impact billing for mammography, breast echography, breast MRI, and ductography from December 2025. Providers must prepa

The upcoming LCD on Non-Invasive Abdominal/Visceral Vascular Studies by WPS may impact billing practices significantly from 2026 onwards. Providers should prepare to adapt their coding and documentati

The new LCD for PET scans related to inflammation and infection will likely affect reimbursement rates and coding practices for related claims. Healthcare providers need to be aware of this update to

The addition of non-invasive arterial duplex ultrasound procedures requires billing team review. However, compliance with the LCD requirements w

The new LCD for Non-invasive Arterial Duplex Ultrasound adds a layer of coverage which could potentially increase the submission of claims for services relating to arterial assessments. Providers may